Viewing Study NCT01015027


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-04-28 @ 8:04 PM
Study NCT ID: NCT01015027
Status: COMPLETED
Last Update Posted: 2013-06-17
First Post: 2009-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers
Sponsor: Regeneron Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: R668-AS-0907
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View